Anheuser-Busch InBev SA/NV
—- Market cap
- $144.41B
- Debt
- —
- Cash
- −$11.64B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: BUD stock price at premium vs AMPH $80.35 current versus $39.39 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at AMPH's multiple
Implied fair value · at BUD's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Premium justified
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: BUD FY 2025 (ended Dec 31, 2025) · AMPH FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 61% equity / 39% debt · EV / Revenue 1.84x · EV / EBITDA 6.20x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Anheuser-Busch InBev SA/NV · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Amphastar Pharmaceuticals, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
—
0.79x
Net debt / EBITDA
Leverage against operating earnings
—
1.58x
Cash and equivalents
Liquid reserves on the balance sheet
$11.64B
$282.81M
Total debt
Interest-bearing obligations outstanding
—
$619.71M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
MOLSON COORS BEVERAGE CO
BUD vs TAP
BOSTON BEER CO INC
BUD vs SAM
CONSTELLATION BRANDS, INC.
BUD vs STZ
Celsius Holdings, Inc.
BUD vs CELH
Tilray Brands, Inc.
BUD vs TLRY
BRISTOL MYERS SQUIBB CO
BUD vs BMY
TEVA PHARMACEUTICAL INDUSTRIES LTD
BUD vs TEVA
Bausch Health Companies Inc.
BUD vs BHC
PERRIGO Co plc
BUD vs PRGO
ANI PHARMACEUTICALS INC
BUD vs ANIP
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.